This has been revealed in the round table 'Biosimilars, making the difference for Rheumatology', held within the framework of the European Congress of Rheumatology (EULAR 2019) which opened this Wednesday in Madrid
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
